{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:23:39Z","timestamp":1786926219965,"version":"build-2736575974"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Drug hypersensitivity reactions (DHRs) to psychiatric medications represent a significant clinical challenge, often resulting in treatment discontinuation, poor adherence, and compromised patient outcomes. Pharmacogenomics has emerged as a promising field for understanding and mitigating these adverse effects by identifying genetic predispositions that affect drug metabolism, immune responses, and individual susceptibility. This narrative review explores the multifaceted mechanisms underlying DHRs, with a focus on immunological pathways, particularly T cell-mediated responses, drug metabolite formation, and genetic risk factors. Among these, human leukocyte antigen (HLA) alleles and polymorphisms in cytochrome P450 (CYP450) enzymes are critical contributors to hypersensitivity development. We provide a comprehensive analysis of pharmacogenomic associations with commonly prescribed psychiatric drugs, including anticonvulsants (e.g., carbamazepine, lamotrigine), selective serotonin reuptake inhibitors (SSRIs), and novel agents such as vortioxetine, psilocybin, and esketamine. Additionally, we examine antipsychotics, including clozapine and newer agents like aripiprazole, brexpiprazole, and cariprazine, highlighting specific gene-drug interactions and known risk alleles such as <jats:italic>HLA-B*15:02, HLA-A*31:01<\/jats:italic>, and variants in <jats:italic>CYP2D6<\/jats:italic> and <jats:italic>CYP1A2<\/jats:italic>. These findings underscore the value of pharmacogenomic testing in predicting and preventing serious DHRs, such as Stevens-Johnson Syndrome, toxic epidermal necrolysis, agranulocytosis, and hepatotoxicity. The review also addresses clinical implementation, discussing the role of pre-emptive genetic screening, emerging guidelines from international consortia such as CPIC and DPWG, and real-world challenges, including variability in test accessibility, ethical concerns, and a lack of standardized protocols across regions. Recent advances in next-generation sequencing and multiomic approaches offer new opportunities to improve predictive accuracy and personalize psychiatric treatment further. Finally, we highlight the importance of population-specific research and global collaboration to close the evidence gap, particularly in underrepresented regions like the Middle East. This review emphasizes the transformative potential of pharmacogenomics in optimizing psychiatric drug therapy, enhancing safety, and ultimately improving patient-centered care.<\/jats:p>","DOI":"10.3389\/fphar.2025.1651898","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:33:11Z","timestamp":1758292391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions"],"prefix":"10.3389","volume":"16","author":[{"given":"Hamid A.","family":"Alhaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Samara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyamama","family":"Alnamous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Karima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Saber-Ayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jaip.2018.05.037","article-title":"Differential expression of alarmins: IL-33 as a candidate marker for early diagnosis of toxic epidermal necrolysis","volume":"7","author":"Adachi","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2000267","DOI":"10.1002\/pmic.202000267","article-title":"Drug hapten\u2010specific t\u2010cell activation: current status and unanswered questions","volume":"21","author":"Adair","year":"2021","journal-title":"PROTEOMICS"},{"key":"B3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/jpm11050383","article-title":"Genetic determinants in HLA and cytochrome P450 genes in the risk of aromatic antiepileptic-induced severe cutaneous adverse reactions","volume":"11","author":"Ahmed","year":"2021","journal-title":"J. Personalized Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40246-022-00417-9","article-title":"Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates","volume":"16","author":"Al-Mahayri","year":"2022","journal-title":"Hum. Genomics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13485","DOI":"10.3390\/ijms232113485","article-title":"Pharmacogenomics in psychiatry practice: the value and the challenges","volume":"23","author":"Alchakee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/ph4010069","article-title":"Drug induced hypersensitivity and the HLA complex","volume":"4","author":"Alfirevic","year":"2010","journal-title":"Pharmaceuticals"},{"key":"B8","first-page":"585","article-title":"Chapter 5.7 adrenal steroids and episodic memory: relevance to mood disorders","volume-title":"Chapter 5.7 adrenal steroids and episodic memory: relevance to mood disorders","author":"Alhaj","year":"2008"},{"key":"B9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jpsychires.2007.11.008","article-title":"Effects of cortisol on the laterality of the neural correlates of episodic memory","volume":"42","author":"Alhaj","year":"2008","journal-title":"J. Psychiatric Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00213-012-2644-x","article-title":"Effect of low-dose acute tryptophan depletion on the specificity of autobiographical memory in healthy subjects with a family history of depression","volume":"222","author":"Alhaj","year":"2012","journal-title":"Psychopharmacology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jaci.2019.05.009","article-title":"Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunity","volume":"144","author":"Almeida","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B12","article-title":"Autoimmunity: from bench to bedside","author":"Anaya","year":"2013"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/10253890310001650277","article-title":"Programming of the hypothalamo\u2013pituitary\u2013adrenal axis: serotonergic involvement","volume":"7","author":"Andrews","year":"2004","journal-title":"Stress"},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000530619","article-title":"Population genome programs across the Middle East and North Africa: successes, challenges, and future directions","volume":"8","author":"Ateia","year":"2023","journal-title":"Biomed. Hub."},{"key":"B15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1177\/0269881115584469","article-title":"Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs","volume":"29","author":"Athanasiu","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/all.13418","article-title":"Identification of T\u2010cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy","volume":"73","author":"Azoury","year":"2018","journal-title":"Allergy"},{"key":"B17","article-title":"Type II hypersensitivity reaction","author":"Bajwa","year":"2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/archdischild-2013-304340","article-title":"What is next generation sequencing?","volume":"98","author":"Behjati","year":"2013","journal-title":"Archives Dis. Child. - Educ. and Pract. Ed."},{"key":"B19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fphar.2016.00396","article-title":"Pharmacogenetics and predictive testing of drug hypersensitivity reactions","volume":"7","author":"B\u00f6hm","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomic testing in psychiatry","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4236\/ojpsych.2013.31008","article-title":"Genomics of schizophrenia and pharmacogenomics of antipsychotic drugs","volume":"3","author":"Cacabelos","year":"2013","journal-title":"Open J. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.psyneuen.2009.05.014","article-title":"Neuronal plasticity: a link between stress and mood disorders","volume":"34","author":"Calabrese","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2045-7022-1-11","article-title":"Allergic diseases in the elderly","volume":"1","author":"Cardona","year":"2011","journal-title":"Clin. Transl. Allergy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/1535370217733425","article-title":"Biomarkers of adverse drug reactions","volume":"243","author":"Carr","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaci.2009.10.031","article-title":"Stimulation of human T cells with sulfonamides and sulfonamide metabolites","volume":"125","author":"Castrejon","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/gim.2016.87","article-title":"Standardizing terms for clinical pharmacogenetic test results: consensus terms from the clinical pharmacogenetics implementation consortium (CPIC)","volume":"19","author":"Caudle","year":"2017","journal-title":"Genet. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cancers17020251","article-title":"Diagnosis and management of skin toxicities in systemic treatment of genitourinary cancers","volume":"17","author":"Chowdhury","year":"2025","journal-title":"Cancers"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1038\/tp.2012.96","article-title":"The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis","volume":"2","author":"Clayden","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"B100","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","article-title":"Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?","volume":"18","author":"Crux","year":"2017","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbr.2016.09.032","article-title":"Association between FKBP5 and CRHR1 genes with suicidal behavior: a systematic review","volume":"317","author":"De la Cruz-Cano","year":"2017","journal-title":"Behav. Brain Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1111\/bcp.15490","article-title":"A concise review of cutaneous adverse drug reactions","volume":"90","author":"Del Pozzo-Maga\u00f1a","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jcph.1946","article-title":"Brexpiprazole pharmacokinetics in CYP2D6 poor metabolizers: using physiologically based pharmacokinetic modeling to optimize time to effective concentrations","volume":"62","author":"Elmokadem","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/17512433.2022.2100345","article-title":"Genetic markers of drug hypersensitivity in pediatrics: current state and promise","volume":"15","author":"Elzagallaai","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cpt.2791","article-title":"Estimating the in vivo function of CYP2D6 alleles through population pharmacokinetic modeling of brexpiprazole","volume":"113","author":"Frederiksen","year":"2023","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/bjd.13162","article-title":"The serum level of HMGB1 (high mobility group box 1 protein) is preferentially high in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"171","author":"Fujita","year":"2014","journal-title":"Br. J. Dermatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1038\/ncomms5757","article-title":"Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles","volume":"5","author":"Goldstein","year":"2014","journal-title":"Nat. Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonz\u00e1lez-Galarza","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/pds.4587","article-title":"Medication\u2010related anaphylaxis treated in hospital: agents implicated, patient outcomes, and management lessons","volume":"27","author":"Graudins","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40779-023-00459-7","article-title":"Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis","volume":"10","author":"Guo","year":"2023","journal-title":"Mil. Med. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"630530","DOI":"10.3389\/fimmu.2021.630530","article-title":"In-Vitro approaches to predict and study T-Cell mediated hypersensitivity to drugs","volume":"12","author":"Hammond","year":"2021","journal-title":"Front. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/toxsci\/kfab144","article-title":"Checkpoint inhibition reduces the threshold for drug-specific T-Cell priming and increases the incidence of sulfasalazine hypersensitivity","volume":"186","author":"Hammond","year":"2022","journal-title":"Toxicol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-024-00514-0","article-title":"Severe cutaneous adverse reactions","volume":"10","author":"Hung","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41397-022-00281-9","article-title":"Pharmacogenomics of clozapine-induced agranulocytosis: a systematic review and meta-analysis","volume":"22","author":"Islam","year":"2022","journal-title":"Pharmacogenomics J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1189976","DOI":"10.3389\/fphar.2023.1189976","article-title":"Pharmacogenomics in practice: a review and implementation guide","volume":"14","author":"Kabbani","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ni.f.216","article-title":"New developments in mast cell biology","volume":"9","author":"Kalesnikoff","year":"2008","journal-title":"Nat. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/2042098613499791","article-title":"The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review","volume":"4","author":"Kaniwa","year":"2013","journal-title":"Ther. Adv. Drug Saf."},{"key":"B46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41397-021-00249-1","article-title":"Economic evaluation in psychiatric pharmacogenomics: a systematic review","volume":"21","author":"Karamperis","year":"2021","journal-title":"Pharmacogenomics J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4168\/aair.2016.8.1.3","article-title":"Update on advances in research on idiosyncratic drug-induced liver injury","volume":"8","author":"Kim","year":"2016","journal-title":"Allergy, Asthma and Immunol. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fphar.2017.00879","article-title":"Association of HLA-A and HLA-B alleles with Lamotrigine-Induced cutaneous adverse drug reactions in the Thai population","volume":"8","author":"Koomdee","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-031-21776-0_1","article-title":"Perspectives of the danger\/injury model of immunology as applied to antigen-related human disorders","volume-title":"Damage-associated molecular patterns in human diseases","author":"Land","year":"2023"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1111\/bcp.15467","article-title":"Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant - implications for precision dosing in a global perspective","volume":"88","author":"Langmia","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"641905","DOI":"10.3389\/fgene.2021.641905","article-title":"Genomic risk factors driving immune-mediated delayed drug hypersensitivity reactions","volume":"12","author":"Li","year":"2021","journal-title":"Front. Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ACI.0000000000000834","article-title":"Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility","volume":"22","author":"Line","year":"2022","journal-title":"Curr. Opin. Allergy and Clin. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced stevens\u2010johnson syndrome is associated with HLA\u2010B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/schbul\/sbaa161","article-title":"A recessively inherited risk locus on chromosome 13q22-31 conferring susceptibility to schizophrenia","volume":"47","author":"Mahmood","year":"2021","journal-title":"Schizophr. Bull."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1182345","DOI":"10.3389\/fpsyt.2023.1182345","article-title":"Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery","volume":"14","author":"Malekpour","year":"2023","journal-title":"Front. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2217\/pgs-2022-0078","article-title":"HLA pharmacogenetic markers of drug hypersensitivity from the perspective of the populations of the greater Middle East","volume":"23","author":"Masmoudi","year":"2022","journal-title":"Pharmacogenomics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1017\/S0033291713001475","article-title":"Somatodendritic 5-hydroxytryptamine1A (5-HT1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone","volume":"44","author":"McAllister-Williams","year":"2014","journal-title":"Psychol. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ACI.0000000000000458","article-title":"Mechanisms leading to T-cell activation in drug hypersensitivity","volume":"18","author":"Meng","year":"2018","journal-title":"Curr. Opin. Allergy and Clin. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5414\/ALX01508E","article-title":"Epidemiology of cutaneous adverse drug reactions","volume":"1","author":"Mockenhaupt","year":"2017","journal-title":"Allergol. Sel."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/cpt.2754","article-title":"Cost effectiveness of pharmacogenetic testing for drugs with clinical pharmacogenetics implementation consortium (CPIC) guidelines: a systematic review","volume":"112","author":"Morris","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"B102","article-title":"Acute Generalized Exanthematous Pustulosis","volume-title":"Acute generalized exanthematous pustulosis","author":"Moore","year":"2023"},{"key":"B63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clindermatol.2018.12.005","article-title":"The rash with maculopapules and fever in children","volume":"37","author":"Muzumdar","year":"2019","journal-title":"Clin. Dermatology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/00002018-200023060-00002","article-title":"Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment","volume":"23","author":"Naisbitt","year":"2000","journal-title":"Drug Saf."},{"key":"B65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.iac.2014.04.009","article-title":"In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs","volume":"34","author":"Naisbitt","year":"2014","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/archdermatol.2011.239","article-title":"High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"147","author":"Nakajima","year":"2011","journal-title":"Archives Dermatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-Presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/toxsci\/kfx084","article-title":"Chemical or drug hypersensitivity: is the immune system clearing the danger?","volume":"158","author":"Pallardy","year":"2017","journal-title":"Toxicol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1016\/j.neuron.2021.09.011","article-title":"Pharmacogenomics: a road ahead for precision medicine in psychiatry","volume":"109","author":"Pardi\u00f1as","year":"2021","journal-title":"Neuron"},{"key":"B71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/FTD.0000000000000842","article-title":"Evolving role of pharmacogenetic biomarkers to predict drug-induced hematological disorders","volume":"43","author":"Pattanaik","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2217\/pgs.12.108","article-title":"HLA and pharmacogenetics of drug hypersensitivity","volume":"13","author":"Pavlos","year":"2012","journal-title":"Pharmacogenomics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13318-020-00650-4","article-title":"Population pharmacokinetics of cariprazine and its major metabolites","volume":"46","author":"Periclou","year":"2021","journal-title":"Eur. J. Drug Metabolism Pharmacokinet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/all.13765","article-title":"Immune pathomechanism and classification of drug hypersensitivity","volume":"74","author":"Pichler","year":"2019","journal-title":"Allergy"},{"key":"B75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0300-483X(02)00255-X","article-title":"The danger Hypothesis\u2014potential role in idiosyncratic drug reactions","volume":"181","author":"Pirmohamed","year":"2002","journal-title":"Toxicology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1365-2222.2007.02742.x","article-title":"Delayed drug hypersensitivity reactions \u2013 new concepts","volume":"37","author":"Posadas","year":"2007","journal-title":"Clin. and Exp. Allergy"},{"key":"B77","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network","volume":"89","author":"Relling","year":"2011","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1267294","DOI":"10.3389\/fphar.2023.1267294","article-title":"Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review","volume":"14","author":"Roberts","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s11096-023-01588-8","article-title":"Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study","volume":"45","author":"Scherf-Clavel","year":"2023","journal-title":"Int. J. Clin. Pharm."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2217\/pgs-2016-0069","article-title":"CYP2D6 *6\/*6 genotype and drug interactions as cause of haloperidol-induced extrapyramidal symptoms","volume":"17","author":"\u0160imi\u0107","year":"2016","journal-title":"Pharmacogenomics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"105009","DOI":"10.1016\/j.ebiom.2024.105009","article-title":"Clinical implementation of preemptive pharmacogenomics in psychiatry","volume":"101","author":"Skokou","year":"2024","journal-title":"EBioMedicine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/jcpt.12118","article-title":"Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers","volume":"39","author":"Song","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/clpt.2011.34","article-title":"Pharmacogenetics: From bench to byte an update of guidelines","volume":"89","author":"Swen","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s40262-024-01431-x","article-title":"Coadministration of cariprazine with a moderate CYP3A4 inhibitor in patients with schizophrenia: implications for dose adjustment and safety monitoring","volume":"63","author":"Szab\u00f3","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"B85","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-031-15130-9_22","article-title":"Drug hypersensitivity reactions","volume-title":"European handbook of dermatological treatments","author":"Szegedi","year":"2023"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1021\/acs.chemrestox.6b00147","article-title":"Mass spectrometric and functional aspects of drug\u2013protein conjugation","volume":"29","author":"Tailor","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"B87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-12-819602-1.00010-3","article-title":"Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions","volume-title":"Psychiatric genomics","author":"Tsermpini","year":"2022"},{"key":"B88","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2500\/aap.2012.33.3561","article-title":"Chapter 28: classification of hypersensitivity reactions","volume":"33","author":"Uzzaman","year":"2012","journal-title":"Allergy Asthma Proc."},{"key":"B89","doi-asserted-by":"publisher","first-page":"AB113","DOI":"10.1016\/j.jaad.2020.06.539","article-title":"12871 A systematic review of drug-induced pemphigoid","volume":"83","author":"Verheyden","year":"2020","journal-title":"J. Am. Acad. Dermatology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/acps.13398","article-title":"Risk factors for clozapine-induced myocarditis and cardiomyopathy: a systematic review and meta-analysis","volume":"145","author":"Vickers","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"B91","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","article-title":"Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland","volume":"20","author":"Wang","year":"2011","journal-title":"Seizure"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e27736","DOI":"10.1097\/MD.0000000000027736","article-title":"CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: case report and review of the literature","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine"},{"key":"B93","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei","year":"2024","journal-title":"J. Am. Acad. Dermatology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jpm10010003","article-title":"Drug use in Denmark for drugs having Pharmacogenomics (PGx) based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 drug\u2013gene pairs: perspectives for introducing PGx test to polypharmacy patients","volume":"10","author":"Westergaard","year":"2020","journal-title":"J. Personalized Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell\u2013mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1017\/S0033291721005250","article-title":"In memory of professor iain wilkinson: cognitive and neuroimaging endophenotypes in a consanguineous schizophrenia multiplex family","volume":"53","author":"Wilkinson","year":"2023","journal-title":"Psychol. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s40262-022-01123-4","article-title":"Prediction of drug-drug interactions after esketamine intranasal administration using a physiologically based pharmacokinetic model","volume":"61","author":"Willemin","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"B98","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jcpt.12780","article-title":"Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: a systematic review and meta-analysis","volume":"44","author":"Zhang","year":"2019","journal-title":"J. Clin. Pharm. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1651898\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:33:14Z","timestamp":1758292394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1651898\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":101,"alternative-id":["10.3389\/fphar.2025.1651898"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1651898","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"1651898"}}